{
    "Trade/Device Name(s)": [
        "Acetaminophen"
    ],
    "Submitter Information": "Sekisui Diagnostics P.E.I. INC.",
    "510(k) Number": "K202644",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081938"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDP"
    ],
    "Summary Letter Date": "November 19, 2021",
    "Summary Letter Received Date": "November 22, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3030"
    ],
    "Regulation Name(s)": [
        "Acetaminophen Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Acetaminophen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube",
        "Lithium heparin mechanical separator",
        "Lithium heparin separator tube",
        "Serum separator tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c Systems",
        "ARCHITECT c8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Spectrophotometric assay"
    ],
    "Methodologies": [
        "Enzymatic (Aryl acylamidase)",
        "Spectrophotometric (2,5-dimethylphenol chromophore)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Sekisui Diagnostics Acetaminophen enzymatic spectrophotometric assay for quantitative measurement of acetaminophen in serum or plasma on ARCHITECT c Systems",
    "Indications for Use Summary": "The Acetaminophen assay is used for the quantitative determination of acetaminophen in human serum or plasma on the ARCHITECT c Systems as an aid in diagnosis and treatment of acetaminophen overdose toxicity.",
    "fda_folder": "Toxicology"
}